Abstract:Background and Objective Severe asthma is a heterogeneous disease with subtype classification according to dominant airway infiltrates, including eosinophilic (Type 2 high), or non‐eosinophilic asthma. Non‐eosinophilic asthma is further divided into paucigranulocytic or neutrophilic asthma characterized by elevated neutrophils, and mixed Type 1 and Type 17 cytokines in the airways. Severe non‐eosinophilic asthma has few effective treatments and many patients do not qualify for biologic therapies. The cystic fibrosis transmembrane conductance regulator (CFTR) is dysregulated in multiple respiratory diseases including cystic fibrosis and chronic obstructive pulmonary disease and has proven a valuable therapeutic target. We hypothesized that the CFTR may also play a role in non‐eosinophilic asthma. Methods Patient‐derived human bronchial epithelial cells (hBECs) were isolated and differentiated at the air‐liquid interface. Single cell RNA‐sequencing (scRNAseq) was used to identify epithelial cell subtypes and transcriptional activity. Ion transport was investigated with Ussing chambers and immunofluorescent quantification of ionocyte abundance in human airway epithelial cells and murine models of asthma. Results We identified that hBECs from patients with non‐eosinophilic asthma had reduced CFTR function, and did not differentiate into CFTR‐expressing ionocytes compared to those from eosinophilic asthma or healthy donors. Similarly, ionocytes were also diminished in the airways of a murine model of neutrophilic‐dominant but not eosinophilic asthma. Treatment of hBECs from healthy donors with a neutrophilic asthma‐like inflammatory cytokine mixture led to a reduction in ionocytes. Conclusion Inflammation‐induced loss of CFTR‐expressing ionocytes in airway cells from non‐eosinophilic asthma may represent a key feature of disease pathogenesis and a novel drug target.

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target

Postnatal Depression and Sexual Health After Childbirth

Targeting Proteases in Cystic Fibrosis Lung Disease: Paradigms, Progress, and Potential.

Immobilized enzymes in organic media: Determinants of water dependence. Progress statement

Neutrophil Elastase and Chronic Lung Disease

Old Players and New Prospects

The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives

Infection and Inflammation in the Cystic fibrosis (CF) airway

Isolation and partial characterization of an interleukin-1-like factor from rat testis interstitial fluid.

Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets

Neutrophil elastase in bronchiectasis

Heterogeneous response of traction force at focal adhesions of vascular smooth muscle cells subjected to macroscopic stretch on a micropillar substrate.

Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL‐1 signaling pathway

Implications for the Microbial Landscape in Cystic Fibrosis

Formoterol Therapy for Chronic Obstructive Pulmonary Disease: A Review of the Literature

Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease

Inflammation‐induced loss of CFTR‐expressing airway ionocytes in non‐eosinophilic asthma

Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.

Mechanisms underlying the roles of leukocytes in the progression of cystic fibrosis

Why don't anti-inflammatories work in cystic fibrosis?